Loading clinical trials...
Loading clinical trials...
EndoPredict is a genomic signature used to determine the 10-year risk of recurrence in early HR+/HER2- breast cancers classified as of intermediate risk according to conventional clinical and patholog...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
NCT07439458 · Acute Exercise, Breast Cancer Cell Lines, and more
NCT07426952 · Breast Cancer Survivorship, Weight Management, and more
NCT07331506 · Breast Cancer Detection, Breast Cancer Early Stage Breast Cancer (Stage 1-3), and more
NCT07071402 · Breast Cancer (Early Breast Cancer)
NCT06478589 · Breast Cancer Survivorship
Hôpital Saint-Louis
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions